Ultrasound CEUS BC: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
Created page with ":Co-chairs: • Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD :Secretary: Julie Lisiecki :Roster: Media: AIUM QIBA Ultrasound V..."
 
mNo edit summary
 
(94 intermediate revisions by 3 users not shown)
Line 1: Line 1:
:Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD                              
:Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD;  Todd Erpelding, PhD, MSE                         
:Secretary: Julie Lisiecki
 
:Roster: [[Media: AIUM QIBA Ultrasound Volume Blood Flow Biomarker Ctte.pdf|(Roster)]]
* [http://tinyurl.com/QIBA-CEUS-Roster Roster]
 


==Project Snapshot==
==Project Snapshot==
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.   
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.   


Under consideration:
'''Project Descriptions:'''
*
*[[Media:Project Description CEUS QIBA final_MA.docx | Project Description / Outline of the group's planned work]]
*[[Media:QIBA CEUS project-summary table.pdf | Summary Table of Project]]
'''CEUS Biomarker Committee Proposal:'''
*[[Media:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA CEUS Biomarker Committee Proposal]]
 
 
==Recent Meetings==
'''Approved Call Summaries:'''
 
*[[Media:2023_07-14 QIBA CEUS BC Call Summary-FINAL.pdf|July 14, 2023]]
*[[Media:05 12 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|May 12, 2023]]
*[[Media:04 14 2023 QIBA CEUS BC Call Summary-FINAL.pdf|April 14, 2023]]
*[[Media:03 10 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 10, 2023]]
*[[Media:02 10 2023 QIBA CEUS BC Call Summary-FINAL.pdf|February 10, 2023]]
*[[Media:01 13 2023 QIBA CEUS BC Call Summary-FINAL.pdf|January 13, 2023]]


==Meetings/Call Summaries==
*[[Media:12 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|December 9, 2022]]
*[[CEUS BC Call Summaries]]
*No calls in October or November
*[[Media:09 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|September 9, 2022]]
*[[Media:08 12 2022 QIBA CEUS BC Call Summary-FINAL-2.pdf|August 12, 2022]]
*[[Media:07 15 2022 QIBA CEUS BC Call Summary-FINAL.pdf|July 15, 2022]]
*[[Media:06 10 2022 QIBA CEUS BC Call Summary-FINAL.pdf|June 10, 2022]]
*[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]]
*[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]]
*[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]]
*[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]]
 
 
'''''[[US CEUS Call Summary Archive]]'''''
 
[[CEUS Task Force (TF) Call Summaries]]


==Working Documents==
==Working Documents==
*[[Media:QIBA CEUS Task Forces - Next Steps.docx| QIBA CEUS Task Forces - Next Steps]]


==Statistical Reference Documents==
==Statistical Reference Documents==


==Workflow Documents==
==Workflow Documents==
Line 31: Line 58:
   
   
==Reference Materials==
==Reference Materials==
Original Proposal to the QIBA Steering Committee
[[File:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf]]


Vendor Press Release
Original Proposal to the QIBA Steering Committee:
[[File:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf]]
*[[Media: QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA Committee for Quantitative Contrast Enhanced Ultrasound Proposal]]
 
Vendor Press Release:
*[[Media:US-20160404-PR_221236_LUMASON_Liver-PR_0.pdf|FDA Approval for LUMASON® Press Release]]


Presentations:
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]]
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]]
*[[Media:x.pdf|text ]]
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin Presentation]]

Latest revision as of 18:48, 21 December 2023

Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE


Project Snapshot

The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.

Project Descriptions:


CEUS Biomarker Committee Proposal:


Recent Meetings

Approved Call Summaries:


US CEUS Call Summary Archive

CEUS Task Force (TF) Call Summaries

Working Documents

Statistical Reference Documents

Workflow Documents

Historical Background - Formation of the Group

Reference Materials

Original Proposal to the QIBA Steering Committee:

Vendor Press Release:

Presentations: